Japanese encephalitis vaccine (live, attenuated) Completed Phase 4 Trials for Encephalitis Prevention

Indications	Status	Purpose	Phase
DBCOND0014278 (Encephalitis)	Completed	Prevention	4

clinicaltrials.gov Identifier	Title	Drugs
NCT02526550	Immunogenicity of a Live Attenuated Chimeric JE Vaccine (IMOJEV) as a Booster Dose in Thai Children Primed With CD.JEVAX	Hepatitis A Vaccine (DB10989) Japanese encephalitis vaccine (live, attenuated) (DB16577) Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) (DB10769)